Article Information
History
- August 13, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Naranjargal J. Dashdorj, PhD1,
- Naranbaatar D. Dashdorj, PhD1,#,
- Mitali Mishra, PhD2,
- Lisa Danzig, MD3,
- Thomas Briese, PhD2,
- W. Ian Lipkin, MD2,#,$ and
- Nischay Mishra, PhD2,#,$
- 1Onom Foundation, Ulaanbaatar, Mongolia
- 2Center for Infection and Immunity, Columbia University, New York, USA
- 3PANDEFENSE Advisory, USA
- ↵#Corresponding author (s) Nischay Mishra, PhD, email: nm2641{at}cumc.columbia.edu, W. Ian Lipkin, MD, email: wil2001{at}cumc.columbia.edu, Naranbaatar D. Dashdorj, PhD, email: nd{at}onomfoundation.org
↵$ NM and WIL equally contributed
Posted August 13, 2021.
Molecular and serological investigation of the 2021 COVID-19 case surge in Mongolian vaccinees
